Delivery Order SPE2DB25D2203-SPE2DB25FPRVX

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $11,166.38 delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $13,241.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a diabetes medication, with a performance period extending to April 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,025.11 firm fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The award is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,633.29 delivery order contract is for the provision of Jardiance 25 mg tablets, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,507.44 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Jardiance 25 mg Tablets, a medication used to treat type 2 diabetes. The award has an ultimate completion date of October 12, 2023 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant $999,999,999 IDC with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,004.81, is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The award is not set aside and is a firm fixed-price delivery order with a performance period through May 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,988.24 firm-fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,793.53 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication for diabetes management. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,360.35, is for the delivery of Jardiance 25 mg tablets. The award is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,248.36, is a delivery order contract for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price agreement, with a performance period extending through May 12, 2025. The contract is not set-aside and was awarded through open competition....
  • SPE2DB25D2203
    Indefinite Delivery Contract
  • SPE2DB25D2203-SPE2DB25FPRVX
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 MG Tablet 90S, a diabetes medication. The firm-fixed-price delivery order, valued at $11,072.61, has a period of performance through May 9, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/10/25, 12:50 AM